These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18000489)

  • 1. How to manage in current treatment of schizophrenic patients.
    Loga S
    Psychiatr Danub; 2007 Dec; 19(4):359-61. PubMed ID: 18000489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatrists between personal freedom to prefer antipsychotic in treatment of schizophrenic patients and algorithms and guidelines.
    Loga S; Loga-Zec S
    Psychiatr Danub; 2010 Jun; 22(2):343-5. PubMed ID: 20562778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing treatment guidelines.
    Miller AL
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):15-6. PubMed ID: 21459734
    [No Abstract]   [Full Text] [Related]  

  • 4. Schizophrenia treatment guidelines in the United States.
    Moore TA
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):40-9. PubMed ID: 21459738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment guidelines for non-schizophrenic psychotic disorders?].
    Jäger M; Frasch K; Weinmann S; Becker T
    Psychiatr Prax; 2007 Nov; 34(8):370-6. PubMed ID: 17806003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European Post-marketing Observational Serdolect (EPOS) Project: increasing our understanding of schizophrenia therapy.
    Wehnert A
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S27-30. PubMed ID: 9690967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a rational pharmacotherapy intervention for inpatients at a psychiatric department.
    Sorensen L; Nielsen B; Stage KB; Brøsen K; Damkier P
    Nord J Psychiatry; 2008; 62(3):242-9. PubMed ID: 18622885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lifelong relapse prevention with antipsychotics in schizophrenia].
    Hasan A; Wobrock T
    Psychiatr Prax; 2010 Sep; 37(6):268-70. PubMed ID: 20803409
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-world antipsychotic treatment practices.
    Moore TA; Covell NH; Essock SM; Miller AL
    Psychiatr Clin North Am; 2007 Sep; 30(3):401-16. PubMed ID: 17720029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Longterm treatment of schizophrenia].
    Pajonk VF
    MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM; Smith L
    Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reaction to "A critical analysis about the diagnostic choice for schizophrenia as starting point of practice guidelines for treatment"].
    Dormaar JM
    Tijdschr Psychiatr; 2006; 48(3):249; author reply 249-50. PubMed ID: 16956090
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of unipolar psychotic depression: the use of evidence in practice guidelines.
    Wijkstra J; Schubart CD; Nolen WA
    World J Biol Psychiatry; 2009; 10(4 Pt 2):409-15. PubMed ID: 17963187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy in the treatment of schizophrenic patients in three University Centers in the Federation of Bosnia and Herzegovina (F/BH).
    Loga-Zec S; Loga S
    Psychiatr Danub; 2011 Mar; 23(1):60-3. PubMed ID: 21448098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia.
    Lawrie S; McIntosh A
    Clin Evid; 2002 Jun; (7):920-44. PubMed ID: 12230716
    [No Abstract]   [Full Text] [Related]  

  • 17. [Poker ala the "mega" studies].
    Kálmán J
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):261-2. PubMed ID: 19419010
    [No Abstract]   [Full Text] [Related]  

  • 18. The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?
    Bushe C; Paton C
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):76-83. PubMed ID: 16280340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
    Buis C; Gourion D; Vaiva G
    Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
    [No Abstract]   [Full Text] [Related]  

  • 20. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
    de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
    Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.